ACUR
Price:
$0.0001
Market Cap:
$6.60K
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1986-03-28
Stock Exchange
OTC
Ticker
ACUR
According to Acura Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -100.01% compared to the average of 68.86 of the last 4 quarters.
The mean historical PE Ratio of Acura Pharmaceuticals, Inc. over the last ten years is -5.86. The current -0.01 PE Ratio has changed -82.93% with respect to the historical average. Over the past ten years (40 quarters), ACUR's PE Ratio was at its highest in in the December 2021 quarter at 325.88. The PE Ratio was at its lowest in in the September 2021 quarter at -21.81.
Average
-5.86
Median
-3.46
Minimum
-25.00
Maximum
-0.63
Discovering the peaks and valleys of Acura Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 376.19%
Maximum Annual PE Ratio = -0.63
Minimum Annual Increase = -168.35%
Minimum Annual PE Ratio = -25.00
| Year | PE Ratio | Change |
|---|---|---|
| 2021 | -25.00 | 376.19% |
| 2020 | -5.25 | 222.40% |
| 2019 | -1.63 | 157.50% |
| 2018 | -0.63 | -44.05% |
| 2017 | -1.13 | -8.21% |
| 2016 | -1.23 | -77.24% |
| 2015 | -5.41 | 224.77% |
| 2014 | -1.67 | -70.97% |
| 2013 | -5.74 | -47.41% |
| 2012 | -10.91 | -168.35% |
The current PE Ratio of Acura Pharmaceuticals, Inc. (ACUR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.63
5-year avg
-6.73
10-year avg
-5.86
Acura Pharmaceuticals, Inc.’s PE Ratio is greater than Filament Health Corp. (-0.53), less than Tian'an Pharmaceutical Co., Ltd. (670.29), greater than Kali, Inc. (-4.28), greater than Curative Biosciences, Inc. (-0.06), greater than Nutranomics, Inc. (-0.07), less than Amazonas Florestal, Ltd (3.28), less than Wayland Group Corp. (-0.00), greater than CNBX Pharmaceuticals Inc. (-0.08), less than GeneLink, Inc. (-0.00), less than G Medical Innovations Holdings Ltd (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.53 | $26.18K | |
| 670.29 | $51.78K | |
| -4.28 | $50.91K | |
| -0.06 | $51.58K | |
| -0.07 | $816.23K | |
| 3.28 | $25.09K | |
| -0.00 | $2.12K | |
| -0.08 | $37.01K | |
| -0.00 | $10.60K | |
| 0 | $51.98K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acura Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acura Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Acura Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Acura Pharmaceuticals, Inc. (ACUR)?
What is the highest PE Ratio for Acura Pharmaceuticals, Inc. (ACUR)?
What is the 3-year average PE Ratio for Acura Pharmaceuticals, Inc. (ACUR)?
What is the 5-year average PE Ratio for Acura Pharmaceuticals, Inc. (ACUR)?
How does the current PE Ratio for Acura Pharmaceuticals, Inc. (ACUR) compare to its historical average?